1-3 of 3
Katherine C. Verbist
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Differential effects of itacitinib, fedratinib, and ruxolitinib in mouse models of hemophagocytic lymphohistiocytosis

Camille Keenan, Sabrin Albeituni, Ninad Oak, Alexa Stroh, Heather S. Tillman, Yingzhe Wang, Burgess B. Freeman, III, Silvia Alemán-Arteaga, Lauren K. Meyer, Rolanda Woods, Katherine C. Verbist, Yinmei Zhou, Cheng Cheng, Kim E. Nichols
Journal: Blood
Blood (2024) 143 (23): 2386–2400.
https://doi.org/10.1182/blood.2023021046
Published: 2024
Includes: Supplemental data
Journal Articles

JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation

Lauren K. Meyer, Katherine C. Verbist, Sabrin Albeituni, Brooks P. Scull, Rachel C. Bassett, Alexa N. Stroh, Heather Tillman, Carl E. Allen, Michelle L. Hermiston, Kim E. Nichols
Journal: Blood
Blood (2020) 136 (6): 657–668.
https://doi.org/10.1182/blood.2020006075
Published: 2020
Includes: Supplemental data
Journal Articles

Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis

Sabrin Albeituni, Katherine C. Verbist, Paige E. Tedrick, Heather Tillman, Jennifer Picarsic, Rachel Bassett, Kim E. Nichols
Journal: Blood
Blood (2019) 134 (2): 147–159.
https://doi.org/10.1182/blood.2019000761
Published: 2019
Includes: Supplemental data